|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Alfacell Corp., of Bloomfield, N.J., presented results confirming that Onconase inhibits the replication of the HIV virus and other viruses in laboratory studies. The results were presented during the congress of the German Society for Virology. Onconase (ranpirnase) is a ribonuclease anticancer drug developed from the eggs of Rana pipiens. Ribonuclease enzymes degrade RNA and interrupt protein synthesis, resulting in the inhibition of cell growth and the induction of apoptosis.
Biacore International AB, of Uppsala, Sweden, said new data demonstrate proof of principle of its surface plasmon resonance array chip technology in relevant biological applications. The ...
Related newspaper, magazine, and journal articles:
|
|
Article: Berna Biotech repositions Rhein Biotech GmbH.
Pharma Marketletter;
May 30, 2005 ;
700+ words
... ... Dusseldorf, Germany-based subsidiary Rhein Biotech GmbH, which it acquired in 2002 along ... latter's parent company, the Dutch Rhein Biotech NV. In future, the German unit will ... partners. "This step will provide Rhein Biotech GmbH with greater market proximity ...
|
|